MICHAEL POWELL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL POWELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL POWELL. MICHAEL POWELL is a Director in Ocera Therapeutics, Inc. ($TZYM) and a Director in Mirna Therapeutics, Inc. ($MIRN) and a Director in Galera Therapeutics, Inc. ($GRTX) and a Director in Checkmate Pharmaceuticals, Inc. ($CMPI).
Companies in which MICHAEL POWELL is an Insider
Checkmate Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL POWELL: Director
Holdings: 3,473,374 shares
Latest Transaction: Nov 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Galera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL POWELL: Director
Holdings: 0 shares
Latest Transaction: Jun 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ocera Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL POWELL: Director
Holdings: 705,368 shares
Latest Transaction: Dec 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNLOGIC, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL POWELL: Director
Holdings: 574,972 shares
Current Value: $1,264,938
Latest Transaction: Jun 07 2019
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MICHAEL POWELL
Sentiment: All, CMPI, GRTX, TZYM, SYBX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | GRTX | Galera Therapeutic ... | POWELL MICHAEL | Director | Option Exercise | A | 8.90 | 13,179 | 117,293 | 13,179 | |
| Nov 12 2020 | CMPI | Checkmate Pharmace ... | POWELL MICHAEL | Director | Option Exercise | A | 10.95 | 30,000 | 328,500 | 30,000 | |
| Aug 12 2020 | CMPI | Checkmate Pharmace ... | POWELL MICHAEL | Director | Option Exercise | C | 0.00 | 3,644,624 | 0 | 0 | |
| Aug 12 2020 | CMPI | Checkmate Pharmace ... | POWELL MICHAEL | Director | Option Exercise | C | 0.00 | 8,753,350 | 0 | 0 | |
| Aug 12 2020 | CMPI | Checkmate Pharmace ... | POWELL MICHAEL | Director | Option Exercise | C | 0.00 | 12,500,000 | 0 | 0 | |
| Aug 12 2020 | CMPI | Checkmate Pharmace ... | POWELL MICHAEL | Director | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,606,707 | 3.5 M to 3.6 M (+3.84 %) |
| Aug 12 2020 | CMPI | Checkmate Pharmace ... | POWELL MICHAEL | Director | Buy | C | 0.00 | 3,473,374 | 0 | 3,473,374 | 0 to 3.5 M |